Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
Installations
Product News
Regulatory
M&A
Market Analysis
Regulatory: Page 3
Bot Image's prostate MRI AI software wins new clearance
By
AuntMinnie.com staff writers
MRI software developer Bot Image has secured an expanded clearance from the U.S. Food and Drug Administration clearance for its ProstatID AI software.
March 27, 2023
Viz.ai nets FDA nod for AAA detection algorithm
By
AuntMinnie.com staff writers
Artificial intelligence (AI) software developer Viz.ai has garnered U.S. Food and Drug Administration (FDA) clearance for its abdominal aortic aneurysm (AAA) detection algorithm.
March 20, 2023
Brainomix secures FDA clearance for stroke AI software
By
AuntMinnie.com staff writers
Artificial intelligence (AI) software developer Brainomix has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its flagship e-ASPECTS stroke imaging software.
March 20, 2023
GE HealthCare recalls certain nuclear medicine systems
By
Amerigo Allegretto
GE HealthCare is recalling its 600 and 800 Series nuclear medicine systems after identifying an issue with two safety mechanisms that could potentially lead to a "catastrophic fall" of a detector and potentially trap or crush patients.
February 15, 2023
Varian secures FDA clearance for Halcyon, Ethos radiotherapy systems
By
AuntMinnie.com staff writers
Varian, a Siemens Healthineers company, has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA), as well as the CE mark, for its Halcyon and Ethos radiotherapy systems featuring its HyperSight technology.
February 1, 2023
Week in review: California radiologist arrested | Breast MRI downgrades BI-RADS 3 lesions | The promise of FAPI-PET
By
Erik L. Ridley
January 6, 2023
FDA approves new drug for Alzheimer's disease
By
Will Morton
Japanese drug developer Eisai has received U.S. Food and Drug Administration (FDA) approval for its Leqembi (lecanemab) treatment for individuals with Alzheimer's disease. The drug is the second of a new category of medications for the disease to go through the FDA's accelerated regulatory pathway.
January 5, 2023
Radiology Patient Action Network praises Congress's Medicare support
By
AuntMinnie.com staff writers
The Radiology Patient Action Network, part of the Radiology Business Management Association (RBMA), is urging long-term fixes for Medicare payments but also praising "limited" congressional support.
December 21, 2022
FDA issues notice on MRI supply delays, shortages
By
AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) is recommending that healthcare providers discuss alternative options for MRI-guided breast biopsy procedures with patients due to supply chain disruptions.
October 31, 2022
Do AI validation studies leave out key information?
By
Amerigo Allegretto
Despite an increase in regulatory approvals, not many artificial intelligence (AI) algorithms for medical imaging cleared by the U.S. Food and Drug Administration (FDA) reveal key information used in clinical studies, researchers have found.
October 30, 2022
ITM-11 gets fast-track nod from FDA
By
AuntMinnie.com staff writers
ITM Isotope Technologies Munich SE's ITM-11 was recently granted fast-track designation by the U.S. Food and Drug Administration (FDA).
October 26, 2022
Intelligent Ultrasound nerve block device gets FDA clearance
By
AuntMinnie.com staff writers
Intelligent Ultrasound Group said its ScanNav Anatomy Peripheral Nerve Block device has been granted de novo clearance for clinical use by the U.S. Food and Drug Administration (FDA).
October 19, 2022
Previous Page
Page 3 of 300
Next Page